Amid tariff news and market volatility, midstream MLPs and corps have been announcing quarterly dividends. Companies are prioritizing returns to shareholders through dividends and buybacks.

Abeona Therapeutics faces a pivotal FDA decision after a CRL-led crash and partial rebound in pz-cel’s valuation. Check out ...